Literature DB >> 17885745

Therapeutic studies in hepatic encephalopathy.

Kevin D Mullen1, Piero Amodio, Marsha Y Morgan.   

Abstract

This article has arisen from presentations made at the 4th International Hannover Conference on Hepatic Encephalopathy held in Dresden, 2006. Each author as listed describes their presentation given as part of a section entitled "Therapeutic Studies in Hepatic Encephalopathy." The first section deals with the justification for placebo-controlled trials in hepatic encephalopathy. The other two sections discuss, in detail, outcome parameters for therapeutic studies in the clinical and research setting, respectively.

Entities:  

Mesh:

Year:  2007        PMID: 17885745     DOI: 10.1007/s11011-007-9061-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  59 in total

1.  Critical flicker frequency for quantification of low-grade hepatic encephalopathy.

Authors:  Gerald Kircheis; Matthias Wettstein; Lars Timmermann; Alfons Schnitzler; Dieter Häussinger
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

2.  Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.

Authors:  R K Dhiman; M S Sawhney; Y K Chawla; G Das; S Ram; J B Dilawari
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

3.  Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.

Authors:  Antoni Mas; Juan Rodés; Lourdes Sunyer; Luís Rodrigo; Ramon Planas; Victor Vargas; Lluís Castells; Dolores Rodríguez-Martínez; Conrado Fernández-Rodríguez; Ignasi Coll; Albert Pardo
Journal:  J Hepatol       Date:  2003-01       Impact factor: 25.083

4.  Neuropsychological aspects of portal-systemic encephalopathy.

Authors:  H Schomerus; W Hamster
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

5.  Attention deficits in minimal hepatic encephalopathy.

Authors:  K Weissenborn; S Heidenreich; J Ennen; N Rückert; H Hecker
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

6.  Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests.

Authors:  P Amodio; F Del Piccolo; P Marchetti; P Angeli; R Iemmolo; L Caregaro; C Merkel; G Gerunda; A Gatta
Journal:  Hepatology       Date:  1999-06       Impact factor: 17.425

7.  A randomized controlled trial of acarbose in hepatic encephalopathy.

Authors:  Sandro Gentile; Giuseppina Guarino; Marco Romano; Ivo A Alagia; Maura Fierro; Stefano Annunziata; Paolo L Magliano; Antonietta G Gravina; Roberto Torella
Journal:  Clin Gastroenterol Hepatol       Date:  2005-02       Impact factor: 11.382

8.  Diabetes mellitus is associated with hepatic encephalopathy in patients with HCV cirrhosis.

Authors:  Samuel H Sigal; Carmen M Stanca; Nickolas Kontorinis; Carol Bodian; Elizabeth Ryan
Journal:  Am J Gastroenterol       Date:  2006-07       Impact factor: 10.864

9.  The importance of bacterial infections as precipating factors of chronic hepatic encephalopathy in cirrhosis.

Authors:  E Strauss; M F da Costa
Journal:  Hepatogastroenterology       Date:  1998 May-Jun

10.  Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy.

Authors:  E Strauss; R Tramote; E P Silva; W R Caly; N Z Honain; R A Maffei; M F de Sá
Journal:  Hepatogastroenterology       Date:  1992-12
View more
  3 in total

Review 1.  Outcomes in Clinical Trials Evaluating Interventions for the Prevention and Treatment of Hepatic Encephalopathy.

Authors:  Lise L Gluud; Rebecca Jeyaraj; Marsha Y Morgan
Journal:  J Clin Exp Hepatol       Date:  2019-02-15

Review 2.  Mechanisms, diagnosis and management of hepatic encephalopathy.

Authors:  Ravi Prakash; Kevin D Mullen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-08-10       Impact factor: 46.802

3.  Management of hepatic encephalopathy.

Authors:  G Wright; A Chattree; R Jalan
Journal:  Int J Hepatol       Date:  2011-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.